Accutane, or isotretinoin, carries a significant risk of severe birth defects. Exposure during pregnancy, even briefly, can lead to malformations affecting the heart, brain, eyes, ears, and face. These defects can be life-threatening or cause lifelong disabilities. The risk is highest during the first trimester, but harm can occur throughout pregnancy.
Understanding the Severity
Studies show a strong correlation between isotretinoin use during pregnancy and major birth defects. The rate of abnormalities is substantially higher than in pregnancies without isotretinoiun exposure. Specific defects range from subtle anomalies to severe, life-altering conditions.
Protecting Yourself and Your Future Pregnancy
Before starting Accutane, you must have a negative pregnancy test and agree to use two forms of effective birth control. Consistent monitoring by a physician is crucial, including regular pregnancy testing throughout treatment. Accutane must be discontinued immediately if a pregnancy is confirmed. Discuss your family planning with your doctor to minimize risks.
Remember, the iPledge program ensures compliance with these safety measures. This program involves regular pregnancy testing and meticulous tracking of medication use. Adherence to iPledge is vital for patient safety.
